Details for Patent: 12,053,502
✉ Email this page to a colleague
Which drugs does patent 12,053,502 protect, and when does it expire?
Patent 12,053,502 protects DAPTOMYCIN and is included in one NDA.
This patent has twelve patent family members in nine countries.
Summary for Patent: 12,053,502
| Title: | Daptomycin formulations |
| Abstract: | The present invention relates to compositions comprising daptomycin and at least one amino acid, methods of providing such compositions and the uses thereof. |
| Inventor(s): | Anita Bevetek Mocnik, Stipica TOMIC, Barbara FUMIC |
| Assignee: | Xellia d o o , Hikma Pharmaceuticals USA Inc |
| Application Number: | US18/363,999 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 12,053,502
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 217415-001 | Jan 30, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | TREATMENT OF THE FOLLOWING INFECTIONS: COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS AND STAPHYLOCOCCUS AUREUS BLOOD STREAM INFECTIONS | ⤷ Start Trial | ||||
| Hikma | DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 217415-002 | Jan 30, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | TREATMENT OF THE FOLLOWING INFECTIONS: COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS AND STAPHYLOCOCCUS AUREUS BLOOD STREAM INFECTIONS | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,053,502
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018322769 | ⤷ Start Trial | |||
| Brazil | 112020003862 | ⤷ Start Trial | |||
| Canada | 3070660 | ⤷ Start Trial | |||
| China | 111093625 | ⤷ Start Trial | |||
| China | 118766886 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
